ConsumerAffairs2d
New drug to treat UTIs gets federal approval
The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and ...
FDA approves new UTI antibiotic that may help patients with recurring infections
Blujepa, which is made by the British pharmaceutical company GSK plc, is approved for the treatment of women and children ...
Fierce Pharma2d
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
No-swim advisory issued for Dubois Park in Jupiter after tests find high levels of bacteria
The advisory does not close Dubois Park, set along the Loxahatchee River near the Jupiter Inlet, or its beach.
Nature2d
A superbug rose to the top after gaining a chemical weapon
A newfound ability to produce an antibiotic helped a strain of antibiotic-resistant bacteria to take over a hospital.
Zacks Investment Research on MSN2d
GSK Secures FDA Nod for Oral Antibiotic to Treat Urinary Tract Infection
GSK plc GSK announced that the FDA has approved its oral antibiotic gepotidacin for treating uncomplicated urinary tract ...
Pharmabiz13h
GSK’s Blujepa receives US FDA nod to treat uncomplicated urinary tract infections in female and paediatric patients 12 years of age and older
GSK’s Blujepa receives US FDA nod to treat uncomplicated urinary tract infections in female and paediatric patients 12 years of age and older: Philadelphia Friday, March 28, 202 ...
Medscape3d
Use of Daptomycin in the Treatment of Vancomycin-Resistant Enterococcal Urinary Tract Infections
Because of the increasing prevalence of VRE infection and the limited treatment options available, we anticipate that management of VRE UTIs will continue to be challenging for the clinician.